Inhibition of Caspases Increases the Sensitivity of L929 Cells to Necrosis Mediated by Tumor Necrosis Factor

Dominique Vercammen(Vlaams Instituut voor Biotechnologie), Rudi Beyaert(Vlaams Instituut voor Biotechnologie), Geertrui Denecker(Vlaams Instituut voor Biotechnologie), Vera Goossens(Vlaams Instituut voor Biotechnologie), Geert Loo(Vlaams Instituut voor Biotechnologie), Wim Declercq(Vlaams Instituut voor Biotechnologie), Johan Grooten(Vlaams Instituut voor Biotechnologie), Walter Fiers(Vlaams Instituut voor Biotechnologie), Peter Vandenabeele(Vlaams Instituut voor Biotechnologie)
The Journal of Experimental Medicine
May 4, 1998
Cited by 917Open Access
Full Text

Abstract

Murine L929 fibrosarcoma cells treated with tumor necrosis factor (TNF) rapidly die in a necrotic way, due to excessive formation of reactive oxygen intermediates. We investigated the role of caspases in the necrotic cell death pathway. When the cytokine response modifier A (CrmA), a serpin-like caspase inhibitor of viral origin, was stably overexpressed in L929 cells, the latter became 1,000-fold more sensitive to TNF-mediated cell death. In addition, TNF sensitization was also observed when the cells were pretreated with Ac-YVAD-cmk or zDEVD-fmk, which inhibits caspase-1- and caspase-3-like proteases, respectively. zVAD-fmk and zD-fmk, two broad-spectrum inhibitors of caspases, also rendered the cells more sensitive, since the half-maximal dose for TNF-mediated necrosis decreased by a factor of 1,000. The presence of zVAD-fmk also resulted in a more rapid increase of TNF-mediated production of oxygen radicals. zVAD-fmk-dependent sensitization of TNF cytotoxicity could be completely inhibited by the oxygen radical scavenger butylated hydroxyanisole. These results indicate an involvement of caspases in protection against TNF-induced formation of oxygen radicals and necrosis.


Related Papers

No related papers found

Powered by citation graph analysis